Marker Therapeutics Stock (NASDAQ: MRKR) stock price, news, charts, stock research, profile.
Open | $4.290 |
Close | $4.300 |
Volume / Avg. | 19.804K / 24.581K |
Day Range | 4.150 - 4.550 |
52 Wk Range | 0.671 - 9.680 |
Market Cap | $37.026M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 2.79% |
Days to Cover | 12.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Marker Therapeutics (NASDAQ: MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Cellectar Biosciences (NASDAQ:CLRB) and Viracta Therapeutics (NASDAQ:VIRX).
The latest price target for Marker Therapeutics (NASDAQ: MRKR) was reported by Roth Capital on Thursday, February 17, 2022. The analyst firm set a price target for 1.00 expecting MRKR to fall to within 12 months (a possible -75.99% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $4.1654 last updated March 28, 2024 at 9:15 AM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.